BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 9536289)

  • 21. Matrix metalloproteinases are involved in C-terminal and interglobular domain processing of cartilage aggrecan in late stage cartilage degradation.
    Little CB; Hughes CE; Curtis CL; Janusz MJ; Bohne R; Wang-Weigand S; Taiwo YO; Mitchell PG; Otterness IG; Flannery CR; Caterson B
    Matrix Biol; 2002 Apr; 21(3):271-88. PubMed ID: 12009333
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cleavage of native cartilage aggrecan by neutrophil collagenase (MMP-8) is distinct from endogenous cleavage by aggrecanase.
    Arner EC; Decicco CP; Cherney R; Tortorella MD
    J Biol Chem; 1997 Apr; 272(14):9294-9. PubMed ID: 9083065
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aggrecan degradation in human intervertebral disc and articular cartilage.
    Sztrolovics R; Alini M; Roughley PJ; Mort JS
    Biochem J; 1997 Aug; 326 ( Pt 1)(Pt 1):235-41. PubMed ID: 9337874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.
    Fraser A; Fearon U; Billinghurst RC; Ionescu M; Reece R; Barwick T; Emery P; Poole AR; Veale DJ
    Arthritis Rheum; 2003 Nov; 48(11):3085-95. PubMed ID: 14613270
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of aggrecan in human knee cartilage and synovial fluid indicates that aggrecanase (ADAMTS) activity is responsible for the catabolic turnover and loss of whole aggrecan whereas other protease activity is required for C-terminal processing in vivo.
    Sandy JD; Verscharen C
    Biochem J; 2001 Sep; 358(Pt 3):615-26. PubMed ID: 11535123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The mechanism of aggrecan release from cartilage differs with tissue origin and the agent used to stimulate catabolism.
    Sztrolovics R; White RJ; Roughley PJ; Mort JS
    Biochem J; 2002 Mar; 362(Pt 2):465-72. PubMed ID: 11853556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Release of hyaluronan and hyaladherins (aggrecan G1 domain and link proteins) from articular cartilage exposed to ADAMTS-4 (aggrecanase 1) or ADAMTS-5 (aggrecanase 2).
    Chockalingam PS; Zeng W; Morris EA; Flannery CR
    Arthritis Rheum; 2004 Sep; 50(9):2839-48. PubMed ID: 15457452
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms involved in cartilage proteoglycan catabolism.
    Caterson B; Flannery CR; Hughes CE; Little CB
    Matrix Biol; 2000 Aug; 19(4):333-44. PubMed ID: 10963994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant human aggrecan G1-G2 exhibits native binding properties and substrate specificity for matrix metalloproteinases and aggrecanase.
    Mercuri FA; Doege KJ; Arner EC; Pratta MA; Last K; Fosang AJ
    J Biol Chem; 1999 Nov; 274(45):32387-95. PubMed ID: 10542281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Highly sulfated glycosaminoglycans inhibit aggrecanase degradation of aggrecan by bovine articular cartilage explant cultures.
    Munteanu SE; Ilic MZ; Handley CJ
    Matrix Biol; 2002 Aug; 21(5):429-40. PubMed ID: 12225808
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chondrocyte-mediated catabolism of aggrecan: aggrecanase-dependent cleavage induced by interleukin-1 or retinoic acid can be inhibited by glucosamine.
    Sandy JD; Gamett D; Thompson V; Verscharen C
    Biochem J; 1998 Oct; 335 ( Pt 1)(Pt 1):59-66. PubMed ID: 9742213
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ADAMTS-1-knockout mice do not exhibit abnormalities in aggrecan turnover in vitro or in vivo.
    Little CB; Mittaz L; Belluoccio D; Rogerson FM; Campbell IK; Meeker CT; Bateman JF; Pritchard MA; Fosang AJ
    Arthritis Rheum; 2005 May; 52(5):1461-72. PubMed ID: 15880348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene deletion of either interleukin-1beta, interleukin-1beta-converting enzyme, inducible nitric oxide synthase, or stromelysin 1 accelerates the development of knee osteoarthritis in mice after surgical transection of the medial collateral ligament and partial medial meniscectomy.
    Clements KM; Price JS; Chambers MG; Visco DM; Poole AR; Mason RM
    Arthritis Rheum; 2003 Dec; 48(12):3452-63. PubMed ID: 14673996
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nitric oxide inhibits aggrecan degradation in explant cultures of equine articular cartilage.
    Bird JL; May S; Bayliss MT
    Equine Vet J; 2000 Mar; 32(2):133-9. PubMed ID: 10743969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neutrophil collagenase (MMP-8) cleaves at the aggrecanase site E373-A374 in the interglobular domain of cartilage aggrecan.
    Fosang AJ; Last K; Neame PJ; Murphy G; Knäuper V; Tschesche H; Hughes CE; Caterson B; Hardingham TE
    Biochem J; 1994 Dec; 304 ( Pt 2)(Pt 2):347-51. PubMed ID: 7998967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coincubation of bovine synovial or capsular tissue with cartilage generates a soluble "Aggrecanase" activity.
    Vankemmelbeke MN; Ilic MZ; Handley CJ; Knight CG; Buttle DJ
    Biochem Biophys Res Commun; 1999 Feb; 255(3):686-91. PubMed ID: 10049771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enzymes active in the areas undergoing cartilage resorption during the development of the secondary ossification center in the tibiae of rats ages 0-21 days: I. Two groups of proteinases cleave the core protein of aggrecan.
    Lee ER; Lamplugh L; Davoli MA; Beauchemin A; Chan K; Mort JS; Leblond CP
    Dev Dyn; 2001 Sep; 222(1):52-70. PubMed ID: 11507769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Role of aggrecanase and MMP in cartilage degradation].
    Ishiguro N; Kojima T
    Clin Calcium; 2004 Jul; 14(7):38-44. PubMed ID: 15577074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a cleavage-site-specific monoclonal antibody for detecting metalloproteinase-derived aggrecan fragments: detection of fragments in human synovial fluids.
    Fosang AJ; Last K; Gardiner P; Jackson DC; Brown L
    Biochem J; 1995 Aug; 310 ( Pt 1)(Pt 1):337-43. PubMed ID: 7544117
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Active matrix metalloproteinases are present in cartilage during immune complex-mediated arthritis: a pivotal role for stromelysin-1 in cartilage destruction.
    van Meurs J; van Lent P; Holthuysen A; Lambrou D; Bayne E; Singer I; van den Berg W
    J Immunol; 1999 Nov; 163(10):5633-9. PubMed ID: 10553093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.